secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zeo ScientifiX, Inc. (ZEOX)
CIK:        0001557376
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001829126-24-006793
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZEO ScientifiX launches monthly regenerative medicine educational series for physicians
--------------------------------------------------------------------------------

- In-person events titled 'The Future of Biologic Medicine' focus on extracellular vesicles and autologous biologics.
- First event held early September 2024; second on October 4; next forum scheduled November 8, 2024 in Davie, FL.
- Events include expert-led discussions, lab tour at Nova Southeastern University, and regulatory overview.
- Company completed Phase 1 trials for flagship product Zofin and is seeking Phase 2 trials for multiple indications.
- Regenerative medicine market projected to reach ~$175B by 2032, 22.8% annual growth rate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557376/000182912624006793/0001829126-24-006793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557376/000182912624006793/zeoscientifix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-24-006793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer